年間 4 号発行
ISSN 印刷: 0731-8898
ISSN オンライン: 2162-6537
Indexed in
Immune Response Against Angiosarcoma Following Lower Fluence Rate Clinical Photodynamic Therapy
要約
Tumor response to photodynamic therapy (PDT) is dependent on treatment parameters used. In particular, the light fluence rate may be an important determinant of the treatment outcome. In this clinical case report, we describe the response of angiosarcoma to PDT carried out using different fluence rates and drug and light doses. A patient with recurrent multifocal angiosarcoma of the head and neck was recruited for PDT. A new generation chlorin-based photosensitizer, Fotolon, was administered at a dose of 2.0 to 5.7 mg/kg. The lesions were irradiated with 665 nm laser light for a light dose of 65 to 200 J/cm2 delivered at a fluence rate of 80 or 150 mW/cm2. High dose PDT carried out at a high fluence rate resulted in local control of the disease for up to a year; however, the disease recurred and PDT had to be repeated. PDT of new lesions carried out at a lower fluence rate resulted in tumor eradication. More significantly, it also resulted in spontaneous remission of neighboring and distant untreated lesions. Repeat PDT carried out on a recurrent lesion at a lower fluence rate resulted in eradication of both treated and untreated lesions despite the lower total light dose delivered. Immunohistochemical examination of biopsy samples implies that PDT could have activated a cell-mediated immune response against untreated lesions. Subsequent histopatho-logical examination of the lesion sites showed negative for disease. Our clinical observations show that lower fluence rate PDT results in better outcome and also indicate that the fluence rate, rather than the total light dose, is a more crucial determinant of the treatment outcome. Specifically, lower fluence rate PDT appears to activate the body's immune response against untreated lesions.
-
Huang Ying-Ying, Tanaka Masamitsu, Vecchio Daniela, Garcia-Diaz Maria, Chang Julie, Morimoto Yuji, Hamblin Michael R, Photodynamic therapy induces an immune response against a bacterial pathogen, Expert Review of Clinical Immunology, 8, 5, 2012. Crossref
-
Kushibiki Toshihiro, Hirasawa Takeshi, Okawa Shinpei, Ishihara Miya, Responses of Cancer Cells Induced by Photodynamic Therapy, Journal of Healthcare Engineering, 4, 1, 2013. Crossref
-
Gollnick Sandra O., Brackett Craig M., Enhancement of anti-tumor immunity by photodynamic therapy, Immunologic Research, 46, 1-3, 2010. Crossref
-
Olivo Malini, Bhuvaneswari Ramaswamy, Lucky Sasidharan Swarnalatha, Dendukuri Nagamani, Soo-Ping Thong Patricia, Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities, Pharmaceuticals, 3, 5, 2010. Crossref
-
Gollnick Sandra, Mechanistic Principles of Photodynamic Therapy, in Biomedical Photonics Handbook, Second Edition, 2014. Crossref
-
Busch Theresa M., Wang Hsing-Wen, Wileyto E. Paul, Yu Guoqiang, Bunte Ralph M., Increasing Damage to Tumor Blood Vessels during Motexafin Lutetium-PDT through Use of Low Fluence Rate, Radiation Research, 174, 3, 2010. Crossref
-
Ding Hui, Lv Yanlin, Ni Dezhi, Wang Jie, Tian Zhiyuan, Wei Wei, Ma Guanghui, Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer, Nanoscale, 7, 21, 2015. Crossref
-
Anzengruber Florian, Avci Pinar, de Freitas Lucas Freitas, Hamblin Michael R., T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?, Photochemical & Photobiological Sciences, 14, 8, 2015. Crossref
-
Bredell Marius G., Besic Emina, Maake Caroline, Walt Heinrich, The application and challenges of clinical PD–PDT in the head and neck region: A short review, Journal of Photochemistry and Photobiology B: Biology, 101, 3, 2010. Crossref
-
Lucky Sasidharan Swarnalatha, Muhammad Idris Niagara, Li Zhengquan, Huang Kai, Soo Khee Chee, Zhang Yong, Titania Coated Upconversion Nanoparticles for Near-Infrared Light Triggered Photodynamic Therapy, ACS Nano, 9, 1, 2015. Crossref
-
Agostinis Patrizia, Berg Kristian, Cengel Keith A., Foster Thomas H., Girotti Albert W., Gollnick Sandra O., Hahn Stephen M., Hamblin Michael R., Juzeniene Asta, Kessel David, Korbelik Mladen, Moan Johan, Mroz Pawel, Nowis Dominika, Piette Jacques, Wilson Brian C., Golab Jakub, Photodynamic therapy of cancer: An update, CA: A Cancer Journal for Clinicians, 61, 4, 2011. Crossref
-
Belicha-Villanueva Alan, Riddell Jonah, Bangia Naveen, Gollnick Sandra O., The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules, Lasers in Surgery and Medicine, 44, 1, 2012. Crossref
-
Weiss Andrea, den Bergh Hubert van, Griffioen Arjan W., Nowak-Sliwinska Patrycja, Angiogenesis inhibition for the improvement of photodynamic therapy: The revival of a promising idea, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1826, 1, 2012. Crossref
-
Yeo Eugenia Li Ling, Cheah Joshua U-Jin, Neo Dawn Jing Hui, Goh Wah Ing, Kanchanawong Pakorn, Soo Khee Chee, Thong Patricia Soo Ping, Kah James Chen Yong, Exploiting the protein corona around gold nanorods for low-dose combined photothermal and photodynamic therapy, Journal of Materials Chemistry B, 5, 2, 2017. Crossref
-
Maeding Nicole, Verwanger Thomas, Krammer Barbara, Boosting Tumor-Specific Immunity Using PDT, Cancers, 8, 10, 2016. Crossref
-
Hamblin Michael Richard, Sabino Caetano Padial, Systemic Effects, in Photodynamic Therapy in Veterinary Medicine: From Basics to Clinical Practice, 2016. Crossref
-
Hamblin Michael R., Photodynamic Therapy and Photobiomodulation: Can All Diseases be Treated with Light?, in Encyclopedia of Modern Optics, 2018. Crossref
-
Gallagher‐Colombo Shannon M., Finlay Jarod C., Busch Theresa M., Tumor Microenvironment as a Determinant of Photodynamic Therapy Resistance, in Resistance to Photodynamic Therapy in Cancer, 5, 2015. Crossref
-
Liu Dihui, Li Bin, Shi Wei, Chen Xiang, Zhao Shuang, A case report of cutaneous angiosarcoma treated by photodynamic therapy with chemotherapy and surgery, Photodiagnosis and Photodynamic Therapy, 25, 2019. Crossref
-
Hameed Sadaf, Mo Shanyan, Mustafa Ghulam, Bajwa Sadia Z., Khan Waheed S., Dai Zhifei, Immunological Consequences of Nanoparticle‐Mediated Antitumor Photoimmunotherapy, Advanced Therapeutics, 3, 5, 2020. Crossref
-
Wilson Brian C., Weersink Robert A., The Yin and Yang of PDT and PTT, Photochemistry and Photobiology, 96, 2, 2020. Crossref
-
Yue Dong, Cai Xiaojun, Fan Mengni, Zhu Jingwu, Tian Jiang, Wu Lihuang, Jiang Qian, Gu Zhongwei, An Alternating Irradiation Strategy‐Driven Combination Therapy of PDT and RNAi for Highly Efficient Inhibition of Tumor Growth and Metastasis, Advanced Healthcare Materials, 10, 8, 2021. Crossref
-
Hamblin Michael R., Abrahamse Heidi, Factors Affecting Photodynamic Therapy and Anti-Tumor Immune Response, Anti-Cancer Agents in Medicinal Chemistry, 21, 2, 2020. Crossref
-
Chin William WL, Thong Patricia SP, Bhuvaneswari Ramaswamy, Soo Khee Chee, Heng Paul WS, Olivo Malini, In-vivo optical detection of cancer using chlorin e6 – polyvinylpyrrolidone induced fluorescence imaging and spectroscopy, BMC Medical Imaging, 9, 1, 2009. Crossref
-
Kabingu Edith, Oseroff Allan R., Wilding Gregory E., Gollnick Sandra O., Enhanced Systemic Immune Reactivity to a Basal Cell Carcinoma Associated Antigen Following Photodynamic Therapy, Clinical Cancer Research, 15, 13, 2009. Crossref
-
Roque III John A., Cole Houston D., Barrett Patrick C., Lifshits Liubov M., Hodges Rachel O., Kim Susy, Deep Gagan, Francés-Monerris Antonio, Alberto Marta E., Cameron Colin G., McFarland Sherri A., Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia, Journal of the American Chemical Society, 144, 18, 2022. Crossref
-
Muchowicz Angelika, Wachowska Malgorzata, Stachura Joanna, Tonecka Katarzyna, Gabrysiak Magdalena, Wołosz Dominika, Pilch Zofia, Kilarski Witold W., Boon Louis, Klaus Tomasz J., Golab Jakub, Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice, European Journal of Cancer, 83, 2017. Crossref
-
Long Shan, Zhao Yibing, Xu Yuanyuan, Li Hui, Zhao Hongyou, Chen Defu, Zeng Jing, Qiu Haixia, Li Xiaosong, Gu Ying, Immune response induced by hematoporphyrin derivatives mediated photodynamic therapy: Immunogenic cell death and elevated costimulatory molecules, Journal of Innovative Optical Health Sciences, 15, 04, 2022. Crossref